Stay updated on Belantamab Combo in Lenalidomide Refractory MM Clinical Trial
Sign up to get notified when there's something new on the Belantamab Combo in Lenalidomide Refractory MM Clinical Trial page.

Latest updates to the Belantamab Combo in Lenalidomide Refractory MM Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision v3.4.2 was added to the record history, and the previous funding notice and revision v3.4.1 were deleted. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1.0%

- Check33 days agoChange DetectedAdded a site-wide funding notice and updated the page revision from v3.4.0 to v3.4.1; these changes do not modify the study record or its history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1.0%

- Check40 days agoChange DetectedThe history page now shows a glossary toggle and uses green additions and red deletions to highlight changes. Revision notes were updated to v3.4.0, replacing the previous v3.3.4; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check54 days agoChange DetectedRevision v3.3.4 was added to the Record History and revision v3.3.3 was removed. This is a minor administrative update to the page’s history.SummaryDifference0.1%

- Check76 days agoChange DetectedRevision: v3.3.3 was added and HHS Vulnerability Disclosure, as well as Revision: v3.3.2, were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check98 days agoChange DetectedThe record history adds a new revision entry (v3.3.2) and removes the previous revision (v3.3.1).SummaryDifference0.1%

Stay in the know with updates to Belantamab Combo in Lenalidomide Refractory MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab Combo in Lenalidomide Refractory MM Clinical Trial page.